Physician profile
David Philip Wright
NPI 1487677282
$123,859.24
in general payments reported to CMS, 2019-2025
13 companies · $17K in 2025
The $17K reported for 2025 was more than what 99% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $28K · 2020: $12K · 2021: $7,189 · 2022: $9,365 · 2023: $12K · 2024: $38K · 2025: $17K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $44K · Consulting Fee: $12K · Travel and Lodging: $6,973 · Food and Beverage: $2,867 · Education: $10.87.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $44,320.00 |
| Consulting Fee | $12,390.00 |
| Travel and Lodging | $6,972.56 |
| Food and Beverage | $2,867.21 |
| Education | $10.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $87,430.43 | 2019-2025 | Biktarvy |
| Merck Sharp & Dohme LLC | $15,110.39 | 2019-2025 | Pifeltro, Delstrigo |
| Janssen Products, Lp | $12,892.27 | 2019-2022 | |
| Viiv Healthcare Company | $5,219.20 | 2019-2025 | Dovato, Apretude, Cabenuva |
| Theratechnologies INC. | $2,580.38 | 2019-2023 | Trogarzo, Egrifta |
| Emd Serono, INC. | $153.15 | 2019-2025 | Serostim |
| Inspire Medical Systems, INC. | $145.67 | 2025 | Inspire |
| Genzyme Corporation | $124.14 | 2024 | |
| Janssen Biotech, INC. | $119.30 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $28.48 | 2022 | |
| Abbvie INC. | $20.98 | 2025 | |
| Janssen Scientific Affairs, LLC | $19.77 | 2019 | |
| Eisai INC. | $15.08 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Wright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.